Does exocrine pancreatic insufficiency lead to iron deficiency and fatigue?

Exocrine pancreatic insufficiency (EPI) leads to a systemic nutritional failure that begins with the breakdown of digestive processes and can manifest as significant iron deficiency and chronic fatigue. The physiological link between these conditions is well-supported by clinical and mechanistic evidence.

Clinical evidence of maldigestion and malabsorption

EPI is defined by a deficit in pancreatic enzymes (lipase, protease, amylase) and bicarbonate, which are essential for processing macronutrients.

• Enzymatic failure: Lipase deficiency is particularly impactful, impairing the breakdown of dietary fats and leading to steatorrhea. Protease and amylase deficits similarly prevent the conversion of proteins and carbohydrates into transportable molecules.
• Consequences: The inability to cleave these nutrients into smaller forms directly results in malabsorption, as the intestinal mucosa cannot absorb undigested complexes. This manifests as weight loss, malnutrition, and deficiencies in fat-soluble vitamins (A, D, E, and K). Pancreatic enzyme replacement therapy (PERT) is the standard clinical intervention to correct these deficits.

Mechanisms of iron deficiency in EPI

The relationship between pancreatic function and iron status is established through the modulation of the duodenal environment.

• pH disruption: Pancreatic bicarbonate normally neutralizes gastric acid. In EPI, diminished bicarbonate secretion leads to an acidic duodenal environment (pH <4). This acidity causes non-heme iron to precipitate as insoluble hydroxides, significantly reducing its bioavailability for uptake by DMT1 transporters.
• Proteolytic release: Adequate digestion requires proteolytic enzymes like trypsin to liberate iron from food matrices. In maldigestive states, this "premucosal" step fails, further reducing available iron. Clinical data from patients with chronic pancreatitis confirm that these mechanisms can lead to iron-deficiency anemia.

Impact of iron deficiency on fatigue

Iron deficiency (ID) is a major contributor to fatigue, occurring even before the onset of clinical anemia.

• Mitochondrial dysfunction: Iron is a critical cofactor for iron-sulfur clusters in the mitochondrial electron transport chain. ID leads to decreased activity in complex I (NADH dehydrogenase), which disrupts ATP production and creates a cellular energy deficit.
• Muscle bioenergetics: Iron is also necessary for myoglobin function. A deficiency impairs oxygen diffusion within muscle cells, increasing the perception of effort during physical activity. Meta-analyses have consistently shown that iron supplementation significantly reduces subjective physical and mental fatigue in iron-deficient individuals.

Bottom line

EPI causes profound maldigestion and malabsorption, primarily through enzyme and bicarbonate deficiencies. This disrupts the duodenal environment necessary for iron uptake and hinders the liberation of iron from food, leading to a deficiency that causes fatigue by impairing cellular ATP production and mitochondrial function.